Peer-review Artikel 2018

  • Oei SL, Thronicke A, Kroz M, Herbstreit C and Schad F. The Internal Coherence of Breast Cancer Patients Is Associated with the Decision-Making for Chemotherapy and Viscum album L. Treatment. Evidence-based complementary and alternative medicine : eCAM. 2018;2018:2-9.
  • Schad F, Axtner J, Kröz M, Matthes H and Steele ML. Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L. Integr Cancer Ther. 2018;17:41-51 LID - 10.1177/1534735416681641 [doi].
  • Schad F, Thronicke A, Merkle A, Steele ML, Kröz M, Herbstreit C and Matthes H. Implementation of an Integrative Oncological Concept in the Daily Care of a German Certified Breast Cancer Center. Complement Med Res. 2018;25:85-91. doi: 10.1159/000478655
  • Schad F, Thronicke A, Steele ML, Merkle A, Matthes B, Grah C and Matthes H. Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis. PLoS One. 2018;13:e0203058.
  • Thronicke A, Kröz M, Merkle A, Matthes H, Herbstreit C and Schad F. Psychosocial, Cognitive, and Physical Impact of Elaborate Consultations and Life Review in Female Patients with Non-Metastasized Breast Cancer. Complement Med Res. 2018;25:92-101. doi: 10.1159/000486672
  • Thronicke A, Oei SL, Merkle A, Herbstreit C, Lemmens H-P, Grah C, Kröz M, Matthes H and Schad F. Integrative cancer care in a certified Cancer Centre of a German Anthroposophic hospital. Complementary Therapies in Medicine. 2018. doi: 10.1016/j.ctim.2018.03.012
  • Thronicke A, Oei SL, Merkle A, Matthes H and Schad F. Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients. Medicines (Basel). 2018;5.

Buchbeiträge 2018